Looking Back : International Practice Patterns in Breast Radiation Oncology From a Case-Based Survey Across 54 Countries During the First Surge of the COVID-19 Pandemic
Oladeru, Oluwadamilola (Mayo Clinic Florida (Jacksonville, Estats Units d'Amèrica). Department of Radiation Oncology)
Dunn, Samantha A. (Massachusetts General Hospital (Boston))
Li, Jian (Massachusetts General Hospital (Boston))
Coles, Charlotte E. (University of Cambridge)
Yamauchi, Chikako (Corona Countermeasures Executing Group of the Japanese Society for Radiation Oncology)
Chang, Jee Suk (Yonsei Cancer Center)
Cheng, Skye Hung-Chun (Koo Foundation Sun Yat-Sen Cancer Center)
Kaidar-Person, Orit (Maastricht University)
Meattini, Icro (Università degli Studi di Firenze)
Ramiah, Duvern (University of the Witwatersrand)
Kirby, Anna (Royal Marsden NHS Foundation Trust and Institute of Cancer Research)
Hijal, Tarek (McGill University Health Centre)
Nader Marta, Gustavo (Hospital Sírio-Libanês)
Poortmans, Philip (Iridium Netwerk and University of Antwerp)
Isern Verdum, Josep (Institut d'Investigació Biomèdica Sant Pau)
Zissiadis, Yvonne (GenesisCare)
Offersen, Birgitte Vrou (Aarhus University Hospital (Aarhus, Dinamarca))
Refaat, Tamer (Loyola University Chicago)
Elsayad, Khaled (University Hospital Muenster (Alemanya))
Hijazi, Hussam (King Abdulaziz University Hospital)
Dengina, Natalia (Ulyanovsk Regional Cancer Center)
Belkacemi, Yazid (University of Paris-Est (UPEC))
Luo, Feng Deng (University of Paris-Est (UPEC))
Lu, Shun (Sichuan Cancer Center)
Griffin, Colleen (Massachusetts General Hospital (Boston))
Collins, Maya (Massachusetts General Hospital (Boston))
Ryan, Phoebe (Massachusetts General Hospital (Boston))
Larios, Dalia (Massachusetts General Hospital (Boston))
Warren, Laura E. (Brigham and Women's Hospital (Boston, Estats Units d'Amèrica))
Punglia, Rinaa S. (Brigham and Women's Hospital (Boston, Estats Units d'Amèrica))
Wong, Julia S. (Brigham and Women's Hospital (Boston, Estats Units d'Amèrica))
Spiegel, Daphna Y. (Beth Israel Deaconess Cancer Center (Boston, Estats Units d'Amèrica))
Jagsi, Reshma (Emory University School of Medicine)
Taghian, Alphonse (Massachusetts General Hospital (Boston))
Bellon, Jennifer R. (Brigham and Women's Hospital (Boston, Estats Units d'Amèrica))
Ho, Alice Y. (Duke University School of Medicine)
Universitat Autònoma de Barcelona

Data:	2023
Resum:	The COVID-19 pandemic has profoundly affected cancer care worldwide, including radiation therapy (RT) for breast cancer (BC), because of risk-based resource allocation. We report the evolution of international breast RT practices during the beginning of the pandemic, focusing on differences in treatment recommendations between countries. Between July and November 2020, a 58-question survey was distributed to radiation oncologists (ROs) through international professional societies. Changes in RT decision making during the first surge of the pandemic were evaluated across six hypothetical scenarios, including the management of ductal carcinoma in situ (DCIS), early-stage, locally advanced, and metastatic BC. The significance of changes in responses before and during the pandemic was examined using chi-square and McNemar-Bowker tests. One thousand one hundred three ROs from 54 countries completed the survey. Incomplete responses (254) were excluded from the analysis. Most respondents were from the United States (285), Japan (117), Italy (63), Canada (58), and Brazil (56). Twenty-one percent (230) of respondents reported treating at least one patient with BC who was COVID-19-positive. Approximately 60% of respondents reported no change in treatment recommendation during the pandemic, except for patients with metastatic disease, for which 57. 7% (636/1,103; P <. 0005) changed their palliative practice. Among respondents who noted a change in their recommendation during the first surge of the pandemic, omitting, delaying, and adopting short-course RT were the most frequent changes, with most transitioning to moderate hypofractionation for DCIS and early-stage BC. Early in the COVID-19 pandemic, significant changes in global RT practice patterns for BC were introduced. The impact of published results from the FAST FORWARD trial supporting ultrahypofractionation likely confounded the interpretation of the pandemic's independent influence on RT delivery.
Drets:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, i la comunicació pública de l'obra, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original. No es permet la creació d'obres derivades.
Llengua:	Anglès
Document:	Article ; recerca ; Versió publicada
Publicat a:	JCO global oncology, Vol. 9 (january 2023) , p. e2300010, ISSN 2687-8941

DOI: 10.1200/GO.23.00010
PMID: 37471670

13 p, 1.3 MB

El registre apareix a les col·leccions:
Documents de recerca > Documents dels grups de recerca de la UAB > Centres i grups de recerca (producció científica) > Ciències de la salut i biociències > Institut de Recerca Sant Pau
Articles > Articles de recerca
Articles > Articles publicats